Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The stimulants revisited.

T E Wilens1, T J Spencer

  • 1Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA. Wilens@helix.mgh.harvard.edu

Child and Adolescent Psychiatric Clinics of North America
|August 17, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.

Molecular psychiatry·2020
Same author

Precision weighting of cortical unsigned prediction error signals benefits learning, is mediated by dopamine, and is impaired in psychosis.

Molecular psychiatry·2020
Same author

Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.

Clinical pharmacology and therapeutics·2017
Same author

Local membrane length conservation in two-dimensional vesicle simulation using a multicomponent lattice Boltzmann equation method.

Physical review. E·2016
Same author

Antidepressant treatment of juvenile depression.

International journal of psychiatry in clinical practice·2014
Same author

Response to Selveraj et al.

Molecular psychiatry·2014
Same journal

Reimagining the Behavioral Health Crisis Care Continuum for Youth.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Addressing the Behavioral Health Needs of Special Populations Within the Youth Crisis Care Continuum.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Technology-Enabled Crisis Care for Youth: Bridging the Gap.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Crisis Phone Services.

Child and adolescent psychiatric clinics of North America·2026
Same journal

A Crisis Care Continuum for Children and Adolescents: The Boston Medical Center Model.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Mobile Response and Stabilization Services.

Child and adolescent psychiatric clinics of North America·2026
See all related articles

Stimulants are frequently prescribed for attention deficit/hyperactivity disorder (ADHD) in youth. This review covers stimulant usage, neurobiology, pharmacology, and management strategies for diverse ADHD populations and comorbidities.

Area of Science:

  • Psychiatry and Pharmacology
  • Pediatric Neurobiology

Background:

  • Stimulants are the most commonly prescribed psychotropic medications for children and adolescents.
  • These medications are primarily used for treating attention deficit/hyperactivity disorder (ADHD).

Purpose of the Study:

  • To summarize the current literature on stimulant usage in pediatric and adolescent populations.
  • To review the neurobiology and pharmacology of stimulant medications.
  • To discuss clinical guidelines and treatment strategies for ADHD, including special populations and comorbidities.

Main Methods:

  • Literature review of recent studies on stimulant prevalence, neurobiology, and pharmacology.
  • Inclusion of research on special ADHD populations (preschoolers, adults) and co-occurring disorders.

Related Experiment Videos

  • Synthesis of clinical guidelines and treatment approaches for managing stimulant therapy.

    • Main Results:

    • Stimulant use is prevalent in children and adolescents for ADHD treatment.
    • Neurobiological and pharmacological profiles of stimulants are well-documented.
    • Evidence supports stimulant use in various ADHD populations, with considerations for comorbidities and adverse effects.

    Conclusions:

    • Stimulants are a cornerstone treatment for ADHD across different age groups.
    • Understanding neurobiology and pharmacology is crucial for effective stimulant management.
    • Comprehensive treatment strategies are necessary for ADHD patients with comorbidities and adverse effects.